Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial.
Sautenet B, Blancho G, Büchler M, Morelon E, Toupance O, Barrou B, Ducloux D, Chatelet V, Moulin B, Freguin C, Hazzan M, Lang P, Legendre C, Merville P, Mourad G, Mousson C, Pouteil-Noble C, Purgus R, Rerolle JP, Sayegh J, Westeel PF, Zaoui P, Boivin H, Le Gouge A, Lebranchu Y. Sautenet B, et al. Among authors: sayegh j. Transplantation. 2016 Feb;100(2):391-9. doi: 10.1097/TP.0000000000000958. Transplantation. 2016. PMID: 26555944 Clinical Trial.
Eight-year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation.
Gatault P, Bertrand D, Büchler M, Colosio C, Hurault de Ligny B, Weestel PF, Rerolle JP, Thierry A, Sayegh J, Moulin B, Snanoudj R, Rivalan J, Heng AE, Sautenet B, Lebranchu Y. Gatault P, et al. Among authors: sayegh j. Transpl Int. 2016 Jan;29(1):41-50. doi: 10.1111/tri.12656. Transpl Int. 2016. PMID: 26285161 Free article. Clinical Trial.
Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation.
Bailly E, Anglicheau D, Blancho G, Gatault P, Vuiblet V, Chatelet V, Morelon E, Malvezzi P, Parissiadis A, Tourret J, Guidicelli G, Sayegh J, Mousson C, Grimbert P, Top I, Le Quintrec M, Purgus R, Westeel PF, Proust B, Chabot V, Lebranchu Y, Dehaut F, Büchler M. Bailly E, et al. Among authors: sayegh j. Transplantation. 2018 Apr;102(4):688-698. doi: 10.1097/TP.0000000000002002. Transplantation. 2018. PMID: 29135832 Clinical Trial.
An extension of the RITUX-ERAH study, multicenter randomized clinical trial comparing rituximab to placebo in acute antibody-mediated rejection after renal transplantation.
Bailly E, Ville S, Blancho G, Morelon E, Bamoulid J, Caillard S, Chatelet V, Malvezzi P, Tourret J, Vuiblet V, Anglicheau D, Bertrand D, Grimbert P, Haidar F, Hazzan M, Kamar N, Merville P, Mousson C, Pernin V, Pouteil-Noble C, Purgus R, Sayegh J, Westeel PF, Sautenet B, Gatault P, Büchler M. Bailly E, et al. Among authors: sayegh j. Transpl Int. 2020 Jul;33(7):786-795. doi: 10.1111/tri.13613. Epub 2020 May 5. Transpl Int. 2020. PMID: 32279367 Free article. Clinical Trial.
Recurrence of Renal Cell Cancer After Renal Transplantation in a Multicenter French Cohort.
Cognard N, Anglicheau D, Gatault P, Girerd S, Essig M, Hurault de Ligny B, Le Meur Y, Le Roy F, Garrouste C, Thierry A, Colosio C, Rivalan J, Sayegh J, Choukroun G, Moulin B, Caillard S. Cognard N, et al. Among authors: sayegh j. Transplantation. 2018 May;102(5):860-867. doi: 10.1097/TP.0000000000002009. Transplantation. 2018. PMID: 29215458
Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.
Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Duong Van Huyen JP, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D. Delville M, et al. Among authors: sayegh j. J Am Soc Nephrol. 2019 Apr;30(4):692-709. doi: 10.1681/ASN.2018080868. Epub 2019 Mar 8. J Am Soc Nephrol. 2019. PMID: 30850439 Free PMC article.
Evaluation of outcomes in renal transplantation with hypothermic machine perfusion for the preservation of kidneys from expanded criteria donors.
Savoye E, Macher MA, Videcoq M, Gatault P, Hazzan M, Abboud I, Thierry A, Bertrand D, Drouin S, Sayegh J, Barrou B, Badet L, Bastien O, Huot O, Lamotte C, Logerot H, Legeai C, Antoine C. Savoye E, et al. Among authors: sayegh j. Clin Transplant. 2019 May;33(5):e13536. doi: 10.1111/ctr.13536. Epub 2019 Apr 10. Clin Transplant. 2019. PMID: 30869162
Chronic Hepatitis C Virus Infection After Kidney Transplantation With or Without Direct-Acting Antivirals in a Real-Life Setting: A French Multicenter Experience.
Chevallier E, Büchler M, Caillard S, Bouvier N, Colosio C, Rivalan J, Sayegh J, Bertrand D, Le Meur Y, Thierry A, Garrouste C, Rerolle JP, Rostaing L, Gatault P. Chevallier E, et al. Among authors: sayegh j. Transplant Proc. 2020 Dec;52(10):3179-3185. doi: 10.1016/j.transproceed.2020.06.005. Epub 2020 Jul 5. Transplant Proc. 2020. PMID: 32636068
Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: Results of a nationwide study.
Lanaret C, Anglicheau D, Audard V, Büchler M, Caillard S, Couzi L, Malvezzi P, Mesnard L, Bertrand D, Martinez F, Pernin V, Ducloux D, Poulain C, Thierry A, Del Bello A, Rerolle JP, Greze C, Uro-Coste C, Aniort J, Lambert C, Bouvier N, Schvartz B, Maillard N, Sayegh J, Oniszczuk J, Morin MP, Legendre C, Kamar N, Heng AE, Garrouste C. Lanaret C, et al. Among authors: sayegh j. Am J Transplant. 2021 Sep;21(9):3021-3033. doi: 10.1111/ajt.16504. Epub 2021 Feb 23. Am J Transplant. 2021. PMID: 33512779 Free article.
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study.
Gatault P, Kamar N, Büchler M, Colosio C, Bertrand D, Durrbach A, Albano L, Rivalan J, Le Meur Y, Essig M, Bouvier N, Legendre C, Moulin B, Heng AE, Weestel PF, Sayegh J, Charpentier B, Rostaing L, Thervet E, Lebranchu Y. Gatault P, et al. Among authors: sayegh j. Am J Transplant. 2017 May;17(5):1370-1379. doi: 10.1111/ajt.14109. Epub 2017 Jan 3. Am J Transplant. 2017. PMID: 27862923 Free article. Clinical Trial.
108 results